<Disease><Name>CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq;CDG-Iq</Name><Synonym>CDG1Q; SRD5A3-CDG</Synonym><OMIM><Number>612379</Number><URL>http://omim.org/entry/612379</URL></OMIM><Orphanet><Number>324737</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=324737</URL></Orphanet><Protein><Number>mutation in the steroid 5-alpha-reductase 3</Number><URL>http://www.uniprot.org/uniprot/Q9H8P0</URL></Protein><ExPASy><Number>1.3.1.22</Number><URL>http://enzyme.expasy.org/EC/1.3.1.22</URL></ExPASy><Gene>4q12</Gene><ICD>E77.8</ICD><Summary>rare;autosomal recessive;mutation in the SRD5A3 gene</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>3155</id><symptom>chorioretinal colobomata</symptom><category>EYES</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2114</id><symptom>ichthyosis</symptom><category>SKIN</category></symtomp><symtomp><id>2468</id><symptom>impaired visual acuity</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2006</id><symptom>skin defects</symptom><category>GENERAL TOPICS | SKIN</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>4220</id><title>SRD5A3-CDG: Expanding the phenotype of a congenital disorder of glycosylation with emphasis on adult onset features</title><author>Wheeler PG;</author><journal>Am J Med Genet A</journal><year>2016</year><book /><volume>170</volume><number>12</number><pages>3165-3171</pages><co_aut>et al.</co_aut></literature><literature><id>3419</id><title>Adult phenotype and further phenotypic variability in SRD5A3-CDG</title><author>Kara B,</author><journal>BMC Med Genet</journal><year>2014</year><book /><volume>15</volume><number>10</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3420</id><title>SRD5A3-CDG: a patient with a novel mutation</title><author>Kasapkara CS,</author><journal>Eur J Paediatr Neurol</journal><year>2012</year><book /><volume>16</volume><number>5</number><pages>554-556</pages><co_aut>et al.</co_aut></literature><literature><id>3418</id><title>SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder</title><author>Cantagrel V,</author><journal>Cell</journal><year>2010</year><book /><volume>142</volume><number>2</number><pages>203-217</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>